Albert Bourla is the Chairman and Chief Executive Officer of Pfizer, one of the world’s leading research-based biopharmaceutical companies. He has been with the company since 1993, and has held various leadership roles in the areas of finance, operations, and business development. He has been instrumental in driving the company’s growth and success, and has been credited with leading the company’s transformation into a global leader in the biopharmaceutical industry. He is a strong advocate for innovation and has been a key player in the development of new treatments and therapies for a variety of diseases. He is also a passionate advocate for public health and has been a leader in the fight against the COVID-19 pandemic.